Search
Search
Faruk Orge, MD; and Darius Moshfeghi, MD
Show Description +
How can ophthalmologists best assess a patient's response to treatment following anti-VEGF therapy for retinopathy of prematurity? Faruk Orge, MD, and Darius Moshfeghi, MD, explore approaches to patient management, discuss tolerance for disease reactivation, and review the role of laser.
Posted: 12/16/2024
Faruk Orge, MD; and Darius Moshfeghi, MD
How can ophthalmologists best assess a patient's response to treatment following anti-VEGF therapy for retinopathy of prematurity? Faruk Orge, MD, and Darius Moshfeghi, MD, explore approaches to patient management, discuss tolerance for disease reactivation, and review the role of laser.
Posted: 12/16/2024
About Regeneron
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, Regeneron's unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in Regeneron's laboratories.
Visit us online: regeneron.com
Follow Regeneron
Copyright © 2024 Regeneron Pharmaceuticals Inc. All rights reserved.
